APOTEEK P. Sergeant SRL
APOTEEK P. Sergeant reported total assets of €1.95m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of APOTEEK P. Sergeant shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APOTEEK P. Sergeant's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 12 Aug 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
APOTEEK P. Sergeant's financial analysis
- Solvency99.2%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APOTEEK P. Sergeant
APOTEEK P. Sergeant's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.105.203
- VAT number
- BE0454105203
- Peppol
- Registered · 0208:0454105203 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Dec 1994
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APOTEEK P. Sergeant (SRL) has been based in Anderlecht since 1994, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 46,948 € and equity of €1.94m; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (37.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to APOTEEK P. Sergeant
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Gans Investors Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €1.97m
- Kevin BULKMANS Retail sale of pharmaceutical products Temse · balance sheet €1.93m
- De VOS Pharma Retail sale of pharmaceutical products Balen · balance sheet €2.00m
- JUVO Retail sale of pharmaceutical products Oudenburg · balance sheet €1.89m
- Stef de Man Retail sale of pharmaceutical products Sint-Truiden · balance sheet €2.02m
- Apotheek Kortessem Retail sale of pharmaceutical products Hasselt · balance sheet €1.86m
- Asapharm Retail sale of pharmaceutical products Gembloux · balance sheet €1.86m
Frequently asked questions about APOTEEK P. Sergeant
What is the revenue of APOTEEK P. Sergeant?
APOTEEK P. Sergeant files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APOTEEK P. Sergeant?
In Belgium, the VAT number is the company number prefixed with BE: BE0454105203 for APOTEEK P. Sergeant, if the company is VAT-registered. Its company number (CBE) is 0454.105.203.
Where is the registered office of APOTEEK P. Sergeant?
According to the CBE register, the registered office of APOTEEK P. Sergeant is in 1070 Anderlecht.
What is the equity of APOTEEK P. Sergeant?
At the close of the 2025 financial year, the equity of APOTEEK P. Sergeant amounts to 1,937,191 €, a solvency of 99.2% of total assets.
Who manages APOTEEK P. Sergeant?
The register lists 1 active mandates at APOTEEK P. Sergeant. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APOTEEK P. Sergeant
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →